Inocras CancerVision, RareVision

Inocras (formerly Genome Insight) has launched two diagnostic whole-genome sequencing tests, CancerVision for solid tumors and RareVision for rare diseases. Both tests are offered with genetic counseling services and support for clinical trial matching. CancerVision is a paired somatic/germline test that sequences the genome at 40X average depth and a panel of 500 actionable genes at 500X depth. It analyzes SNVs, indels, structural variants, copy number variants, tumor mutational burden, microsatellite instability, and homologous recombination deficiency. RareVision sequences the genome at 30X average depth and looks for SNVs, indels, structural variants, and copy number variants.